Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma

被引：0
|
作者：
Massarelli, Erminia
Ginsberg, Lawrence E.
Lin, Heather
Tran, Hai T.
Lee, J. Jack
Williams, Michelle D.
Blumenschein, George R.
Lu, Charles
Kies, Merrill S.
Papadimitrakopoulou, Vassiliki
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6067
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II trial of irinotecan plus cisplatin in patients with recurrent or metastatic squamous carcinoma of the head and neck (RMHNC).
    Ikpeazu, CV
    Murphy, BA
    Kish, B
    Cmelak, A
    Shyr, Y
    Netterville, J
    Burkey, B
    Chung, C
    Yarbrough, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 508S - 508S
  • [32] WEEKLY REGIMEN OF PACLITAXEL-CARBOPLATIN-CETUXIMAB AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH PLATINUM-RESISTANT RECURRENT OR METASTATIC SQUAMOUS CELL CARCINOMA OF HEAD AND NECK (SSCHN): RESULTS OF A PHASE II STUDY
    Rozzi, A.
    Lenci, G.
    Corona, M.
    Nardoni, C.
    Restuccia, M. R.
    Falbo, T.
    Nappa, M.
    Costa, A. M.
    Spigone, B.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 323 - 323
  • [33] Platinum resistance and sensitivity in recurrent/metastatic head and neck squamous cell carcinoma
    Horichi, Yuto
    Matsui, Hidetoshi
    Yamamura, Yuta
    Iwae, Shigemichi
    AURIS NASUS LARYNX, 2024, 51 (01) : 132 - 137
  • [34] Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Taguchi, Jun
    Shimizu, Yasushi
    Ariga, Shin
    Goda, Tomohiro
    Ohhara, Yoshihito
    Honma, Rio
    Noguchi, Takuro
    Takeuchi, Satoshi
    Kinoshita, Ichiro
    Amano, Toraji
    Mizumachi, Takatsugu
    Kano, Satoshi
    Takahara, Miki
    Abe, Takahisa
    Homma, Akihiro
    Dosaka-Akita, Hirotoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (01) : 51 - 58
  • [35] Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Jun Taguchi
    Yasushi Shimizu
    Shin Ariga
    Tomohiro Goda
    Yoshihito Ohhara
    Rio Honma
    Takuro Noguchi
    Satoshi Takeuchi
    Ichiro Kinoshita
    Toraji Amano
    Takatsugu Mizumachi
    Satoshi Kano
    Miki Takahara
    Takahisa Abe
    Akihiro Homma
    Hirotoshi Dosaka-Akita
    International Journal of Clinical Oncology, 2021, 26 : 51 - 58
  • [36] Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma
    Shin, DM
    Glisson, BS
    Khuri, FR
    Ginsberg, L
    Papadimitrakopoulou, V
    Lee, JJ
    Lawhorn, K
    Gillenwater, AM
    Ang, KK
    Clayman, GL
    Callender, DL
    Hong, WK
    Lippman, SM
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1325 - 1330
  • [37] Phase 1 Clinical Trial of Re-irradiation With Pemetrexed and Erlotinib Followed by Maintenance Erlotinib for Patients With Recurrent and Second Primary Squamous Cell Carcinoma of the Head and Neck Management of Recurrent Head-and-Neck Squamous Cell Carcinoma
    Porosnicu, M.
    Greven, K. M.
    Sullivan, C. A.
    Waltonen, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 508 - 508
  • [38] Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas
    William, William N., Jr.
    Tsao, Anne S.
    Feng, Lei
    Ginsberg, Lawrence E.
    Lee, J. Jack
    Kies, Merrill S.
    Glisson, Bonnie S.
    Kim, Edward S.
    ONCOLOGIST, 2018, 23 (05): : 526 - +
  • [39] A phase II trial of sorafenib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC): A Southwest Oncology Group (SWOG) trial
    Williamson, S. K.
    Moon, J.
    Huang, C. H.
    Guaglianone, P.
    Wolf, G. T.
    Urba, S. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    NATURE MEDICINE, 2023, 29 (04) : 880 - 887
12345